Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750125 · ClinicalTrials.gov registry record
Validation of Pulse Wave Doppler Demodulation Algorithm for the Continuous, Non-invasive Measurement of Blood Flow Velocity
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 10
- Enrollment target
NCT01750125: Completed study, sponsored by University of Virginia.
NCT01750125 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01750125 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The investigators hypothesize that performance of fast-Fourier transformation on the raw Doppler signals obtained from ascending aortic blood flow will recreate the pulse wave Doppler trace visualized on modern echocardiography machines, and that this will allow for the measurement and recording of vascular flow waveforms
Primary Outcome
Estimated arterial flow waveform using fast Fourier transformation (FFT) will be compared to the pulse wave Doppler trace from the device
Interventions
- DEVICE measure ascending aortic blood flow with pulse wave Doppler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-01 |
What the finished NCT01750125 record still lists
NCT01750125 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which measure ascending aortic blood flow with pulse wave Doppler is the first listed.
NCT01750125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01750125 about?
NCT01750125 is a clinical study titled "Validation of Pulse Wave Doppler Demodulation Algorithm for the Continuous, Non-invasive Measurement of Blood Flow Velocity". The investigators hypothesize that performance of fast-Fourier transformation on the raw Doppler signals obtained from ascending aortic blood flow will recreate the pulse wave Doppler trace visualized on modern echocardiography machines, and that this will allow for the measurement and recording of ...
What is the current status of trial NCT01750125?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-12. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01750125?
The interventions under investigation include: measure ascending aortic blood flow with pulse wave Doppler (DEVICE).
Who is sponsoring clinical trial NCT01750125?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia